Upregulation of GBP1 in thyroid primordium is required for developmental thyroid morphogenesis

Rui-Meng Yang,Ming Zhan,Qin-Yi Zhou,Xiao-Ping Ye,Feng-Yao Wu,Mei Dong,Feng Sun,Ya Fang,Rui-Jia Zhang,Chang-Run Zhang,Liu Yang,Miao-Miao Guo,Jun-Xiu Zhang,Jun Liang,Feng Cheng,Wei Liu,Bing Han,Yi Zhou,Shuang-Xia Zhao,Huai-Dong Song

DOI: https://doi.org/10.1038/s41436-021-01237-3

IF: 8.864

2021-10-01

Genetics in Medicine

Abstract:Congenital hypothyroidism (CH) is a common congenital endocrine disorder in humans. CH-related diseases such as athyreosis, thyroid ectopy, and hypoplasia are primarily caused by dysgenic thyroid development. However, the underlying molecular mechanisms remain unknown.

genetics & heredity

What problem does this paper attempt to address?

This paper aims to explore the role of the GBP1 gene in congenital hypothyroidism (CH) and its molecular mechanisms. Specifically, the study attempts to address the following questions:

1. **Identify new CH candidate genes**: Look for new pathogenic genes in patients not carrying known CH - related gene variants through exon sequencing (ES).
2. **Verify the functional impact of GBP1 variants**: Verify whether the identified GBP1 variants are pathogenic through in vitro cell experiments and zebrafish models.
3. **Explore the role of GBP1 in thyroid development**: Study the function of GBP1 in the morphogenesis of the embryonic thyroid primordium (TP), especially its impact on cell - cell adhesion and cell rearrangement.
4. **Elucidate the mechanism of action of GBP1**: Explore how GBP1 inhibits the formation of cell - cell adhesion complexes by affecting the cytoplasmic localization of β - catenin, thereby regulating thyroid development.

### Research Background
Congenital hypothyroidism (CH) is a common congenital endocrine disorder, mainly caused by thyroid dysplasia (TD). Although some genes related to CH are known, these genes can only explain a small number of TD cases, so further exploration of unknown genetic and epigenetic factors is required.

### Methods
1. **Clinical sample collection and exon sequencing**: Perform targeted gene sequencing on 192 CH patients and conduct whole - exon sequencing on 98 of them who do not carry known CH - related gene variants.
2. **Functional verification**: Use thyroid epithelial cell lines and zebrafish models to verify the functional impact of the identified GBP1 variants.
3. **Molecular mechanism research**: Study the role of GBP1 in cell - cell adhesion and β - catenin localization through techniques such as immunofluorescence, Western Blot, and co - immunoprecipitation.

### Results
1. **Four pathogenic GBP1 variants were identified**: Four pathogenic GBP1 variants were found in three CH patients.
2. **Zebrafish model verification**: Knockdown of gbp1 in zebrafish led to defects in thyroid primordium morphogenesis and hypothyroidism. Overexpression of wild - type human GBP1 (hGBP1) could restore these defects, while overexpression of mutant hGBP1 could not.
3. **GBP1 promotes the cytoplasmic localization of β - catenin**: GBP1 regulates the growth and differentiation of the thyroid primordium by promoting the cytoplasmic localization of β - catenin and inhibiting the formation of cell - cell adhesion complexes.

### Conclusions
This study provides new insights into thyroid development, indicating that GBP1 plays a crucial role in regulating the morphogenesis of the embryonic thyroid primordium. Defects in cell rearrangement may lead to congenital hypothyroidism.